Markus F. Neurath
I Medical Clinic and Institute of Molecular Medicine
Johannes Gutenberg University of Mainz
Mainz
Germany
Name/email consistency: high
- Is chromoendoscopy the new standard for cancer surveillance in patients with ulcerative colitis? Neurath, M.F., Kiesslich, R. Nat. Clin. Pract. Gastroenterol. Hepatol (2009)
- IL-12 family members in experimental colitis. Neurath, M.F. Mucosal. Immunol (2008)
- An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Neufert, C., Becker, C., Neurath, M.F. Nat. Protoc (2007)
- New therapies for sepsis: focus on the interleukin (IL)12 family member IL27. Neurath, M.F. Ann. Rheum. Dis. (2007)
- 6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease. Neurath, M.F., Kiesslich, R., Teichgräber, U., Fischer, C., Hofmann, U., Eichelbaum, M., Galle, P.R., Schwab, M. Clin. Gastroenterol. Hepatol. (2005)
- Mucosal immunity in Crohn's disease. Neurath, M.F. Inflamm. Bowel Dis. (2004)
- The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. Neurath, M.F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., Mizoguchi, E., Mudter, J., Galle, P.R., Bhan, A., Autschbach, F., Sullivan, B.M., Szabo, S.J., Glimcher, L.H., Blumberg, R.S. J. Exp. Med. (2002)
- T-bet as a possible therapeutic target in autoimmune disease. Weigmann, B., Neurath, M.F. Expert Opin. Ther. Targets (2002)
- Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Neurath, M.F., Finotto, S., Fuss, I., Boirivant, M., Galle, P.R., Strober, W. Trends Immunol. (2001)
- Signals on the immune tract. Neurath, M.F. Gut (2001)
- Immunotherapy of inflammatory bowel diseases: current concepts and future perspectives. Neurath, M.F. Arch. Immunol. Ther. Exp. (Warsz.) (2000)